{"id":"https://openalex.org/W2565264183","doi":"https://doi.org/10.1182/blood.v112.11.2102.2102","title":"Platinum-Based Compounds Induce Expression of p73 and Restores Drug- Sensitivity in p53 Dysfunctional Chronic Lymphocytic Leukemia (CLL) Cells.","display_name":"Platinum-Based Compounds Induce Expression of p73 and Restores Drug- Sensitivity in p53 Dysfunctional Chronic Lymphocytic Leukemia (CLL) Cells.","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2565264183","doi":"https://doi.org/10.1182/blood.v112.11.2102.2102","mag":"2565264183"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.2102.2102","doi":"https://doi.org/10.1182/blood.v112.11.2102.2102","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.2102.2102","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012638755","display_name":"Sanne H. Tonino","orcid":"https://orcid.org/0000-0002-3253-8759","observed_orcids":["https://orcid.org/0000-0002-3253-8759"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sanne H. Tonino","raw_affiliation_strings":["Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083331481","display_name":"Chantal Mulkens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Chantal Mulkens","raw_affiliation_strings":["Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yoshinori Nonomura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshinori Nonomura","raw_affiliation_strings":["Moores Cancer Center, University of California San Diego, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer Center, University of California San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019698374","display_name":"Guangli Suo","orcid":"https://orcid.org/0000-0003-4381-3864","observed_orcids":["https://orcid.org/0000-0003-4381-3864"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guangli Suo","raw_affiliation_strings":["Moores Cancer Center, University of California San Diego, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer Center, University of California San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["Moores Cancer Ctr., Univ. of California, San Diego, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer Ctr., Univ. of California, San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109986453","display_name":"Marinus H. J. van Oers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marinus H.J. van Oers","raw_affiliation_strings":["Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044751799","display_name":"Eric Eldering","orcid":"https://orcid.org/0000-0003-0561-6640","observed_orcids":["https://orcid.org/0000-0003-0561-6640"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Eric Eldering","raw_affiliation_strings":["Department of Hematology and Experimental Immunology, Academic Medical Center, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Experimental Immunology, Academic Medical Center, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064164625","display_name":"Arnon Philip Kater","orcid":"https://orcid.org/0000-0003-3190-1891","observed_orcids":["https://orcid.org/0000-0003-3190-1891"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["NL","US"],"is_corresponding":false,"raw_author_name":"Arnon P. Kater","raw_affiliation_strings":["Department of Hematology, Academic Medical Center and University of California San Diego, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Academic Medical Center and University of California San Diego, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35430984,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"2102","last_page":"2102"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/p73","display_name":"p73","score":0.8989999890327454},{"id":"https://openalex.org/keywords/p53-dysfunction","display_name":"p53 dysfunction","score":0.9010000228881836},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9610000252723694},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/c-abl","display_name":"c-Abl","score":0.9070000052452087},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.8830000162124634},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.8069999814033508},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5730000138282776},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.4779999852180481},{"id":"https://openalex.org/keywords/fas","display_name":"Fas","score":0.6119999885559082},{"id":"https://openalex.org/keywords/bid","display_name":"Bid","score":0.9309999942779541},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.7409999966621399},{"id":"https://openalex.org/keywords/mec-1-cells","display_name":"MEC-1 cells","score":0.8539999723434448},{"id":"https://openalex.org/keywords/cd40-ligation","display_name":"CD40 ligation","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7939331531524658},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.6789641976356506},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6187372207641602},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.46759268641471863},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41888588666915894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39790210127830505},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37910181283950806},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3783944845199585},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3693130910396576},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.29951220750808716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22010710835456848},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.13019490242004395}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.2102.2102","doi":"https://doi.org/10.1182/blood.v112.11.2102.2102","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.2102.2102","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2163846505"],"related_works":["https://openalex.org/W2039711032","https://openalex.org/W2551499806","https://openalex.org/W2163846505","https://openalex.org/W2553044056","https://openalex.org/W2492343070","https://openalex.org/W2530145297","https://openalex.org/W2534128519","https://openalex.org/W2106033763","https://openalex.org/W2586379992","https://openalex.org/W1786636902"],"abstract_inverted_index":{"Abstract":[0],"Chronic":[1],"lymphocytic":[2],"leukemia":[3],"(CLL)":[4],"cells":[5,33,68,113,136,152,171,179,225,235,246,250,278,318,333,361],"can":[6,82,326],"lose":[7],"function":[8],"of":[9,24,43,102,105,111,133,147,177,187,198,214,223,233,244,287,296,303,308,316,323,330,349],"P53":[10,26],"and":[11,87,121,145,167,200,209,255,281,284,299,371],"acquire":[12],"resistance":[13],"to":[14,50,137,261,334,345],"standard":[15,138],"chemotherapy.":[16],"We":[17,107,141],"found":[18,78],"that":[19,79,109,122,172,313],"expression":[20,42,125,197,213,295,322],"P73,":[21,199,324],"a":[22,37,270],"member":[23],"the":[25,100,143,161,224,227,262,328,347,372],"family,":[27],"could":[28,118,218],"be":[29,83,128,219],"induced":[30,84,124,184],"in":[31,85,189,237,258,266,288,353,369],"CLL":[32,67,112,135,151,170,249,277,317,332,360],"following":[34,92],"CD40-ligation":[35],"via":[36,269],"c-abl":[38],"dependent":[39,272,321],"pathway.":[40,273],"Induced":[41],"P73":[44,80,120,298,304],"was":[45,193],"associated":[46,129],"with":[47,70,94,114,130,159,168,180,226,252,355],"re-acquired":[48,131],"sensitivity":[49,132,260,329],"drugs":[51,335],"commonly":[52],"used":[53],"treat":[54],"this":[55,103],"disease,":[56],"such":[57,115,123,336],"as":[58,337],"Fludarabine":[59],"monophosphate.":[60,339],"Similar":[61],"effects":[62,146],"also":[63,81,117,126],"were":[64,157],"noted":[65],"for":[66,99],"transduced":[69],"an":[71],"adenovirus":[72],"vector":[73],"encoding":[74,206],"P731.":[75],"Prior":[76],"studies":[77],"breast":[86],"colon":[88],"cancer":[89],"cell":[90,238],"lines":[91],"treatment":[93,110,232,243,291,315],"platinum-based":[95,148,350],"compounds,":[96],"potentially":[97],"accounting":[98],"activity":[101,348],"class":[104],"drugs.":[106,140],"hypothesized":[108],"compound":[116],"induce":[119],"might":[127],"P53-deficient":[134,248,331],"anti-cancer":[139],"studied":[142],"mechanisms":[144],"compounds":[149],"on":[150],"lacking":[153,362],"functional":[154,174,363],"p53.":[155],"Studies":[156],"done":[158],"both":[160,297],"p3":[162],"dysfunctional":[163,276],"pro-lymphocytic":[164],"celline":[165],"MEC-1":[166,178,234,245],"primary":[169],"lacked":[173],"P53.":[175],"Treatment":[176],"cisplatinum":[181,290],"or":[182,247],"oxaliplatin":[183],"nuclear":[185],"translocation":[186],"c-Abl":[188,228,271,320],"several":[190],"hours,":[191],"which":[192,325,365],"subsequently":[194],"followed":[195],"by":[196,221],"then":[201],"its":[202],"putative":[203],"target":[204],"genes,":[205],"Bid,":[207,300],"p21":[208],"Fas":[210],"(CD95).":[211],"Platinum-induced":[212],"these":[215],"P73-target":[216],"genes":[217],"inhibited":[220],"co-treatment":[222],"inhibitor":[229],"imatinib.":[230],"Cisplatinum":[231],"resulted":[236,257],"cycle":[239],"arrest.":[240],"Furthermore,":[241],"cis-platinum":[242],"synergized":[251],"Fas-mediated":[253],"apoptosis,":[254],"importantly":[256],"acquired":[259],"drug":[263],"fludarabine":[264,338],"monophosphate":[265],"vitro,":[267],"apparently":[268],"Purified":[274],"p53":[275],"obtained":[279],"before":[280],"after":[282],"24":[283],"48":[285],"hrs":[286],"vivo":[289],"revealed":[292],"de":[293],"novo":[294],"illustrating":[301],"induction":[302],"at":[305],"therapeutic":[306],"dosages":[307],"cisplatin.":[309],"This":[310],"study":[311],"indicates":[312],"platinum":[314],"induces":[319],"enhance":[327],"These":[340],"results":[341],"provide":[342],"additional":[343],"incentive":[344],"investigate":[346],"chemotherapy":[351],"regimens":[352],"patients":[354],"refractory":[356],"disease":[357],"who":[358],"have":[359],"P53,":[364],"currently":[366],"are":[367],"ongoing":[368],"Europe":[370],"United":[373],"States.":[374]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}